Mutations that enhance the ciprofloxacin resistance of Escherichia coli with qnrA1

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 3, 2016, Pages 1537-1545

  Vinué, Laura ^a,b   Corcoran, Marian A ^a   Hooper, David C ^b   Jacoby, George A ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) A; GENTAMICIN; KANAMYCIN; LIPOPOLYSACCHARIDE; MERCURIC CHLORIDE; NALIDIXIC ACID; NOVOBIOCIN; QUINOLONE DERIVATIVE; STREPTOMYCIN; SULFONAMIDE; TOBRAMYCIN; TRIMETHOPRIM; ACRA PROTEIN, E COLI; ACRB PROTEIN, E COLI; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CARRIER PROTEIN; DNA BINDING PROTEIN; ESCHERICHIA COLI PROTEIN; LIPOPROTEIN; MARA PROTEIN, E COLI; MARR PROTEIN, E COLI; MDTE PROTEIN, E COLI; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; OUTER MEMBRANE PROTEIN F; PORIN; QNR PROTEIN, E COLI; REPRESSOR PROTEIN; SOXR PROTEIN, BACTERIA; SOXS PROTEIN, E COLI; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BIOSYNTHESIS; DNA SEQUENCE; ESCHERICHIA COLI; GENE MUTATION; MARR GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QNRA1 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOXR GENE; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; GENETICS; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CIPROFLOXACIN; DNA GYRASE; DNA-BINDING PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NOVOBIOCIN; PORINS; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 84960193089     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02167-15     Document Type: Article

References (56)

1. Martínez-Martínez L, Pascual A, Jacoby GA. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797-799. http://dx.doi.org/10.1016/S0140-6736 (97) 07322-4.
2. Hooper DC. 2003. Mechanisms of quinolone resistance, p 41-67. In Hooper DC, Rubinstein E (ed), Quinolone antimicrobial agents, 3rd ed. ASM Press, Washington, DC.
3. Fabrega A, Madurga S, Giralt E, Vila J. 2009. Mechanism of action of and resistance to quinolones. Microb Biotechnol 2:40-61. http://dx.doi.org/10.1111/j.1751-7915.2008.00063.x.
4. Cesaro A, Bettoni RR, Lascols C, Merens A, Soussy CJ, Cambau E. 2008. Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes. J Antimicrob Chemother 61:1007-1015. http://dx.doi.org/10.1093/jac/dkn077.
5. Jacoby GA, Han P. 1996. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 34:908-911.
6. Tran JH, Jacoby GA. 2002. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci U S A 99:5638-5642. http://dx.doi.org/10.1073/pnas.082092899.
7. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, Bush K, Hooper DC. 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 12:83-88. http://dx.doi.org/10.1038/nm1347.
8. Périchon B, Courvalin P, Galimand M. 2007. Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob Agents Chemother 51:2464-2469. http://dx.doi.org/10.1128/AAC.00143-07.
9. Hedges RW. 1974. R factors from Providence. J Gen Microbiol 81:171-181. http://dx.doi.org/10.1099/00221287-81-1-171.
10. CLSI. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 9th ed. CLSI document M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Simons RW, Houman F, Kleckner N. 1987. Improved single and multicopy lac-based cloning vectors for protein and operon fusions. Gene 53:85-96. http://dx.doi.org/10.1016/0378-1119 (87) 90095-3.
12. Miller JH. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
13. Drlica K. 2003. The mutant selection window and antimicrobial resistance. J Antimicrob Chemother 52:11-17. http://dx.doi.org/10.1093/jac/dkg269.
14. McHugh GL, Swartz MN. 1977. Elimination of plasmids from several bacterial species by novobiocin. Antimicrob Agents Chemother 12:423-426. http://dx.doi.org/10.1128/AAC.12.3.423.
15. Duval V, McMurry LM, Foster K, Head JF, Levy SB. 2013. Mutational analysis of the multiple-antibiotic resistance regulator MarR reveals a ligand binding pocket at the interface between the dimerization and DNA binding domains. J Bacteriol 195:3341-3351. http://dx.doi.org/10.1128/JB.02224-12.
16. Alekshun MN, Levy SB. 1999. The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol 7:410-413. http://dx.doi.org/10.1016/S0966-842X (99) 01589-9.
17. Koutsolioutsou A, Pena-Llopis S, Demple B. 2005. Constitutive soxR mutations contribute to multiple-antibiotic resistance in clinical Escherichia coli isolates. Antimicrob Agents Chemother 49:2746-2752. http://dx.doi.org/10.1128/AAC.49.7.2746-2752.2005.
18. Eguchi Y, Oshima T, Mori H, Aono R, Yamamoto K, Ishihama A, Utsumi R. 2003. Transcriptional regulation of drug efflux genes by EvgAS, a two-component system in Escherichia coli. Microbiology 149:2819-2828. http://dx.doi.org/10.1099/mic.0.26460-0.
19. Hirakawa H, Inazumi Y, Masaki T, Hirata T, Yamaguchi A. 2005. Indole induces the expression of multidrug exporter genes in Escherichia coli. Mol Microbiol 55:1113-1126.
20. Deng Z, Shan Y, Pan Q, Gao X, Yan A. 2013. Anaerobic expression of the gadE-mdtEF multidrug efflux operon is primarily regulated by the twocomponent system ArcBA through antagonizing the H-NS mediated repression. Front Microbiol 4:194. http://dx.doi.org/10.3389/fmicb.2013.00194.
21. Nishino K, Yamasaki S, Hayashi-Nishino M, Yamaguchi A. 2011. Effect of overexpression of small non-coding DsrA RNA on multidrug efflux in Escherichia coli. J Antimicrob Chemother 66:291-296. http://dx.doi.org/10.1093/jac/dkq420.
22. Valvano MA, Messner P, Kosma P. 2002. Novel pathways for biosynthesis of nucleotide-activated glycero-manno-heptose precursors of bacterial glycoproteins and cell surface polysaccharides. Microbiology 148:1979-1989. http://dx.doi.org/10.1099/00221287-148-7-1979.
23. Hirai K, Aoyama H, Suzue S, Irikura T, Iyobe S, Mitsuhashi S. 1986. Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. Antimicrob Agents Chemother 30:248-253. http://dx.doi.org/10.1128/AAC.30.2.248.
24. Chapman JS, Georgopapadakou NH. 1988. Routes of quinolone permeation in Escherichia coli. Antimicrob Agents Chemother 32:438-442. http://dx.doi.org/10.1128/AAC.32.4.438.
25. Helling RB, Janes BK, Kimball H, Tran T, Bundesmann M, Check P, Phelan D, Miller C. 2002. Toxic waste disposal in Escherichia coli. J Bacteriol 184:3699-3703. http://dx.doi.org/10.1128/JB.184.13.3699-3703.2002.
26. Webber MA, Whitehead RN, Mount M, Loman NJ, Pallen MJ, Piddock LJ. 2015. Parallel evolutionary pathways to antibiotic resistance selected by biocide exposure. J Antimicrob Chemother 70:2241-2248. http://dx.doi.org/10.1093/jac/dkv109.
27. Goto K, Kawamura K, Arakawa Y. 2015. Contribution of QnrA, plasmidmediated quinolone resistance peptide, to survival of Escherichia coli exposed to lethal ciprofloxacin concentration. Jpn J Infect Dis 68:196-202. http://dx.doi.org/10.7883/yoken. JJID.2014.153.
28. Martínez-Martínez L, Pascual A, García I, Tran J, Jacoby GA. 2003. Interaction of plasmid and host quinolone resistance. J Antimicrob Chemother 51:1037-1039. http://dx.doi.org/10.1093/jac/dkg157.
29. Briales A, Rodriguez-Martinez JM, Velasco C, Diaz de Alba P, Dominguez-Herrera J, Pachon J, Pascual A. 2011. In vitro effect of qnrA1, qnrB1, and qnrS1 genes on fluoroquinolone activity against isogenic Escherichia coli isolates with mutations in gyrA and parC. Antimicrob Agents Chemother 55:1266-1269. http://dx.doi.org/10.1128/AAC.00927-10.
30. Lascols C, Robert J, Cattoir V, Bébéar C, Cavallo JD, Podglajen I, Ploy MC, Bonnet R, Soussy CJ, Cambau E. 2007. Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene. Int J Antimicrob Agents 29:402-409. http://dx.doi.org/10.1016/j.ijantimicag.2006.11.008.
31. Yang J, Luo Y, Li J, Ma Y, Hu C, Jin S, Ye L, Cui S. 2010. Characterization of clinical Escherichia coli isolates from China containing transferable quinolone resistance determinants. J Antimicrob Chemother 65:453-459. http://dx.doi.org/10.1093/jac/dkp478.
32. Ruiz E, Saenz Y, Zarazaga M, Rocha-Gracia R, Martinez-Martinez L, Arlet G, Torres C. 2012. qnr, aac (6])-Ib-cr and qepA genes in Escherichia coli and Klebsiella spp.: genetic environments and plasmid and chromosomal location. J Antimicrob Chemother 67:886-897. http://dx.doi.org/10.1093/jac/dkr548.
33. Machuca J, Briales A, Labrador G, Diaz-de-Alba P, Lopez-Rojas R, Docobo-Perez F, Martinez-Martinez L, Rodriguez-Bano J, Pachon ME, Pascual A, Rodriguez-Martinez JM. 2014. Interplay between plasmidmediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli. J Antimicrob Chemother 69:3203-3215. http://dx.doi.org/10.1093/jac/dku308.
34. Swick MC, Morgan-Linnell SK, Carlson KM, Zechiedrich L. 2011. Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance. Antimicrob Agents Chemother 55:921-924. http://dx.doi.org/10.1128/AAC.00996-10.
35. Bohnert JA, Schuster S, Fahnrich E, Trittler R, Kern WV. 2007. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF). J Antimicrob Chemother 59:1216-1222. http://dx.doi.org/10.1093/jac/dkl426.
36. Morita Y, Kodama K, Shiota S, Mine T, Kataoka A, Mizushima T, Tsuchiya T. 1998. NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob Agents Chemother 42:1778-1782.
37. Yang S, Clayton SR, Zechiedrich EL. 2003. Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli. J Antimicrob Chemother 51:545-556. http://dx.doi.org/10.1093/jac/dkg126.
38. Jellen-Ritter AS, Kern WV. 2001. Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants selected with a fluoroquinolone. Antimicrob Agents Chemother 45:1467-1472. http://dx.doi.org/10.1128/AAC.45.5.1467-1472.2001.
39. Marcusson LL, Frimodt-Moller N, Hughes D. 2009. Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLoS Pathog 5:e1000541. http://dx.doi.org/10.1371/journal.ppat.1000541.
40. Kim E, Chen C, Braun M, Kim HY, Okumura R, Wang Y, Jacoby GA, Hooper DC. 2015. Interactions between QnrB, QnrB mutants, and DNA gyrase. Antimicrob Agents Chemother 59:5413-5419. http://dx.doi.org/10.1128/AAC.00771-15.
41. Tropp BE, Ragolia L, Xia W, Dowhan W, Milkman R, Rudd KE, Ivanisevic R, Savic DJ. 1995. Identity of the Escherichia coli cls and nov genes. J Bacteriol 177:5155-5157.
42. Bernard S, Clarke DJ, Chen MX, Holland IB, Jacq A. 1998. Increased sensitivity of E. coli to novobiocin, EDTA and the anticalmodulin drugW7 following overproduction of DjlA requires a functional transmembrane domain. Mol Gen Genet 259:645-655. http://dx.doi.org/10.1007/PL00008629.
43. Modrzewska M, Karpinski P, Grudniak A, Wolska KI. 2002. Effect of null mutations in dnaK and dnaJ genes on conjugational DNA transfer, proteolysis and novobiocin susceptibility of Escherichia coli. Acta Microbiol Pol 51:217-224.
44. Adachi S, Hiraga S. 2003. Mutants suppressing novobiocin hypersensitivity of a mukB null mutation. J Bacteriol 185:3690-3695. http://dx.doi.org/10.1128/JB.185.13.3690-3695.2003.
45. Zhong M, Ferrell B, Lu W, Chai Q, Wei Y. 2013. Insights into the function and structural flexibility of the periplasmic molecular chaperone SurA. J Bacteriol 195:1061-1067. http://dx.doi.org/10.1128/JB.01143-12.
46. Tamaki S, Sato T, Matsuhashi M. 1971. Role of lipopolysaccharides in antibiotic resistance and bacteriophage adsorption of Escherichia coli K-12. J Bacteriol 105:968-975.
47. Pazoles CJ, Kulpa CF, Jr. 1977. Biosynthesis and structure of lipopolysaccharide in an outer membrane-defective mutant of Escherichia coli J5. Biochim Biophys Acta 466:160-175. http://dx.doi.org/10.1016/0005-2736 (77) 90216-4.
48. Linkevicius M, Sandegren L, Andersson DI. 2013. Mechanisms and fitness costs of tigecycline resistance in Escherichia coli. J Antimicrob Chemother 68:2809-2819. http://dx.doi.org/10.1093/jac/dkt263.
49. Delcour AH. 2009. Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta 1794:808-816. http://dx.doi.org/10.1016/j.bbapap. 2008.11.005.
50. Huguet A, Pensec J, Soumet C. 2013. Resistance in Escherichia coli: variable contribution of efflux pumps with respect to different fluoroquinolones. J Appl Microbiol 114:1294-1299. http://dx.doi.org/10.1111/jam.12156.
51. Forst S, Delgado J, Inouye M. 1989. Phosphorylation of OmpR by the osmosensor EnvZ modulates expression of the ompF and ompC genes in Escherichia coli. Proc Natl Acad Sci U S A 86:6052-6056. http://dx.doi.org/10.1073/pnas.86.16.6052.
52. Batchelor E, Walthers D, Kenney LJ, Goulian M. 2005. The Escherichia coli CpxA-CpxR envelope stress response system regulates expression of the porins ompF and ompC. J Bacteriol 187:5723-5731. http://dx.doi.org/10.1128/JB.187.16.5723-5731.2005.
53. Clarke EJ, Voigt CA. 2011. Characterization of combinatorial patterns generated by multiple two-component sensors in E. coli that respond to many stimuli. Biotechnol Bioeng 108:666-675. http://dx.doi.org/10.1002/bit.22966.
54. Chou JH, Greenberg JT, Demple B. 1993. Posttranscriptional repression of Escherichia coli OmpF protein in response to redox stress: positive control of the micF antisense RNA by the soxRS locus. J Bacteriol 175:1026-1031.
55. Chen S, Zhang A, Blyn LB, Storz G. 2004. MicC, a second small-RNA regulator of Omp protein expression in Escherichia coli. J Bacteriol 186:6689-6697. http://dx.doi.org/10.1128/JB.186.20.6689-6697.2004.
56. Jacoby GA, Strahilevitz J, Hooper DC. 2014. Plasmid-mediated quinolone resistance. Microbiol Spectr 2: PLAS-0006-2013. http://dx.doi.org/10.1128/microbiolspec. PLAS-0006-2013.